Acadia Healthcare Company, INC Form 4 insider transactions

Christopher H. Hunter, CEO of Acadia Healthcare Company, Inc., reported the disposal of 1,899 shares of common stock on May 9, 2024.

John S. Hollinsworth, EVP of Operations at Acadia Healthcare Company, Inc., reported the disposal of 552 shares of common stock on April 23, 2024, to cover tax obligations.

John S. Hollinsworth, EVP of Operations at Acadia Healthcare Company, Inc., reported the disposition of 496 shares of common stock to cover tax obligations.

Christopher H. Hunter, CEO of Acadia Healthcare Company, Inc., reported the disposal of 1,485 shares of common stock on April 11, 2024.

EVP of Operations at Acadia Healthcare, John S. Hollinsworth, disposed of 2,803 shares of common stock to cover tax obligations.

Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare Company, Inc. on March 5, 2024, at an average price of $85.39 per share.

Director Vicky B. Gregg sold 2,500 shares of Acadia Healthcare Company, Inc. on March 4, 2024, at a weighted average price of $85.56 per share.

Heather Brianne Dixon, CFO of Acadia Healthcare Company, Inc., acquired 21,560 shares of common stock on February 28, 2024, based on 2023 performance under performance vesting restricted stock units.

Brian Farley, EVP, GC and Secretary of Acadia Healthcare Company, Inc., reports acquiring 4,680 shares of common stock on February 28, 2024, based on 2023 performance.

John S. Hollinsworth, EVP of Operations at Acadia Healthcare Company, Inc., reports acquisition and disposal of company stock on February 28, 2024.

Christopher H. Hunter, CEO of Acadia Healthcare Company, Inc., reports acquiring shares of common stock based on performance vesting restricted stock units.

Christopher Hunter, CEO of Acadia Healthcare, files an amended Form 4 to correct the number of shares awarded as restricted stock due to a clerical error.